ASLAN is a Singapore-based biotechnology company that develops and commercializes novel medicines for the treatment of oncology and immunology... Read more
ASLAN is a Singapore-based biotechnology company that develops and commercializes novel medicines for the treatment of oncology and immunology... Read more
News
Jul 18, 2024
The Pharma Letter
ASLAN Pharmaceuticals: Aslan files for voluntary liquidation
Jun 14, 2024
MarketScreener
ASLAN Pharmaceuticals: ASLAN PHARMACEUTICALS : ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE Form 6 K
May 09, 2024
BioSpace
ASLAN Pharmaceuticals: ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 07, 2024
Benzinga
ASLAN Pharmaceuticals: ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
May 02, 2024
BioSpace
ASLAN Pharmaceuticals: ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
Apr 30, 2024
GlobeNewswire
Press Release: ASLAN Pharmaceuticals : ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab
Apr 24, 2024
Benzinga
ASLAN Pharmaceuticals: ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
Apr 22, 2024
Nasdaq
ASLAN Pharmaceuticals: Aslan Announces Positive Results For Phase 2 Study Of Eblasakimab In AD Patients
Apr 16, 2024
Owler
ASLAN Pharmaceuticals Pte. Ltd.: ASLAN Pharmaceuticals's employee count changed from 34 in Dec 2022 to 35 in Dec 2023
Apr 12, 2024
Marketscreener
ASLAN Pharmaceuticals: ASLAN Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023
